Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 646530, 12 pages
http://dx.doi.org/10.1155/2015/646530
Review Article

Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

1Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
2The 2nd Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China

Received 19 May 2015; Accepted 17 August 2015

Academic Editor: Kristine McGrath

Copyright © 2015 Pengda Liao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. D. White and D. P. Chew, “Acute myocardial infarction,” The Lancet, vol. 372, no. 9638, pp. 570–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, “Current concepts of the pathogenesis of the acute coronary syndromes,” Circulation, vol. 104, no. 3, pp. 365–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. World Bank, Toward a Healthy and Harmonious Life in China: Stemming the Rising Tide of Non-Communicable Diseases, World Bank, Washington, DC, USA, 2011.
  4. X.-J. Ma, H.-J. Yin, and K.-J. Chen, “Appraisal of the prognosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention,” Chinese Journal of Integrative Medicine, vol. 15, no. 3, pp. 236–240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Tanaka, T. Kawarabayashi, Y. Nishibori et al., “No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction,” Circulation, vol. 105, no. 18, pp. 2148–2152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-X. Liu, S.-R. Wang, Y. Lei, and J.-J. Shang, “Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 269–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K.-J. Chen, K. K. Hui, M. S. Lee, and H. Xu, “The potential benefit of complementary/alternative medicine in cardiovascular diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 125029, 1 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Dobos and I. Tao, “The model of Western integrative medicine: the role of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 11–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Sun, J.-J. Zhang, J.-Z. Shan et al., “Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma,” Phytomedicine, vol. 16, no. 8, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. O. Cheng, “Cardiovascular effects of Danshen,” International Journal of Cardiology, vol. 121, no. 1, pp. 9–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. F. Y. Lam, J. H. K. Yeung, K. M. Chan, and P. M. Or, “Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels,” Vascular Pharmacology, vol. 46, no. 4, pp. 271–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. F. Y. Lam, J. H. K. Yeung, Y. W. Kwan, K. M. Chan, and P. M. Y. Or, “Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels,” European Journal of Pharmacology, vol. 553, no. 1–3, pp. 240–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Su, Y. He, W. Yang, Y. Wang, W. Zhang, and Y. Wang, “Effect of dan hong injection on PON1, SOD activity and mda levels in elderly patients with coronary heart disease,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 12, pp. 5886–5889, 2014. View at Google Scholar · View at Scopus
  14. S.-Y. Han, H.-X. Li, X. Ma, K. Zhang, Z.-Z. Ma, and P.-F. Tu, “Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro,” Phytomedicine, vol. 16, no. 8, pp. 694–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zhou, L. Tang, Y. Xu, G. Zhou, and Z. Wang, “Towards a better understanding of medicinal uses of Carthamus tinctorius L. in traditional Chinese medicine: a phytochemical and pharmacological review,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 27–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Q. Jiang, “Effect of danhong injection of patients with coronary artery disease on platelet activation and blood coagulation function,” China Modern Doctor, no. 14, pp. 68–70, 2011. View at Google Scholar
  17. S. J. Li, Y. P. Tang, J. Shen, J. P. Li, G. J. Ming, and J. A. Duan, “Research of Chinese medicine pairs (VIII)—salviae miltiorrhizae radix et rhizoma-carthami flos,” China Journal of Chinese Materia Medica, vol. 24, 2013. View at Google Scholar
  18. G. F. Guan, X. P. Hua, L. Wang, L. Du, and X. H. Kong, “The effects of Danhong injection on vascular inflammation in rabbit model with atherosclerosis,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 10, pp. 304–306, 2006. View at Google Scholar
  19. Chinese Society of Cardiology of Chinese Medical Association and Editorial Board of Chinese Journal of Cardiology, “Guideline for diagnosis and treatment of patients with unstable angina and non-ST-segment elevation myocardial infarction,” Chinese Journal of Cardiology, vol. 35, no. 4, pp. 295–304, 2007. View at Google Scholar
  20. Chinese Society of Cardiology of Chinese Medical Association and Editorial Board of Chinese Journal of Cardiology, “Recommendation of the application of universal definition of myocardial infarction in China,” Chinese Journal of Cardiology, vol. 36, no. 10, pp. 867–869, 2008. View at Google Scholar
  21. China Society of Cardiology of Chinese Medical Association and Editorial Board of Chinese Journal of Cardiology, “Guideline for diagnosis and treatment of patients with ST-elevation myocardial infarction,” Chinese Journal of Cardiology, vol. 38, no. 8, pp. 675–690, 2010. View at Google Scholar · View at Scopus
  22. H. Jneid, J. L. Anderson, R. S. Wright et al., “2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 60, no. 7, pp. 645–681, 2012. View at Google Scholar
  23. E. A. Amsterdam, N. K. Wenger, R. G. Brindis et al., “2014 AHA/acc guideline for the management of patients with Non-ST-Elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 64, no. 24, pp. e139–e228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. X. D. Gao, P. S. Zhou, and W. W. Kang, “Clinical effect of emergency interventional therapy combined with Danhong injection in the treatment of acute myocardial infarction,” Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, no. 6, pp. 28–29, 2008. View at Google Scholar
  25. X. Gui, “Research on Danhong injection combined with thrombolysis for acute myocardial infarction,” Journal of Medical Forum, no. 21, pp. 73–74, 2009. View at Google Scholar
  26. “Effect of Danhong injection combined with urokinase thrombolysis for 80 acute myocardial infarction patients,” in Proceedings of the 1st National Critical Care Medicine Academic Conference of Integrated Traditional Chinese and Western Medicine and the Founding Conference of Chinese Critical Care Medicine Professional Committe of Integrated Traditional Chinese and Western Medicine, Z. R. Qiao, Q. J. Dong, S. L. Du, C. L. Yuan, and Y. J. Xue, Eds., Guangzhou, China, 2010.
  27. J. X. Han, “Effect of Danhong injection combined with thrombolytic therapy on reperfusion in early acute myocardial infarction,” Chinese Journal of Misdiagnostics, no. 15, p. 3556, 2010. View at Google Scholar
  28. Y. J. Jin, Z. X. Li, and L. Z. Jin, “Myocardial protection effects of Danhong injection in acute myocardial infarction patients receiving thrombolytic therapy for recanalization,” Chinese General Practice, no. 32, pp. 3678–3680, 2011. View at Google Scholar
  29. H. M. Tian, “Effect of Danhong injection in the treatment of acute ST segment elevated myocardial infarction,” Liaoning Journal of Traditional Chinese Medicine, no. 11, pp. 2206–2207, 2011. View at Google Scholar
  30. X. Y. Hao and L. Ren, “Danhong injection combined with urokinase thrombolysis therapy for 60 early acute myocardial infarction patients,” Shanxi Journal of Traditional Chinese Medicine, no. 10, pp. 1284–1285, 2011. View at Google Scholar
  31. S. R. Zhao, “Investigation of short and long term myocardial protection of Danhong injection on thrombolysis patients with acute myocardial infarction,” Hebei Journal of Traditional Chinese Medicine, no. 10, pp. 1528–1530, 2012. View at Google Scholar
  32. G. J. Han, W. H. Liu, D. W. Yang, Z. Y. Gao, J. W. Cao, and L. Y. Zhang, “Effect observation of Danhong injection acute myocardial infarction and myocardial ischemia/reperfusion injury,” People's Military Surgeon, no. 6, pp. 514–515, 2012. View at Google Scholar
  33. G. S. Zhang, The clinical research on reperfusion trauma after thrombolysis in acute myocardial infarction of Qi deficiency and blood stasis syndrome by the effect of Danhong injection [Ph.D. thesis], Fujian University of Traditional Chinese Medicine, Fujian, China, 2012.
  34. J. J. Lu, The Protective Effects and Mechanism of Danhong Injection on Myocardial Ischemia-Reperfusion Injury, Nanjing University of Chinese Medicine, Nanjing, China, 2012.
  35. H. F. Fan and G. Zheng, “Effect of Danhong injection combined with urokinase thrombolysis for early acute myocardial infarction patients,” Modern Diagnosis & Treatment, no. 18, p. 4123, 2013. View at Google Scholar
  36. Y. N. Qu, C. Y. Yu, and F. X. Ren, “Observation of Danhong Injection's short term effect on st-segment elevated acute myocardial infarction patients with different GRADE scores,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, no. 11, pp. 1321–1322, 2013. View at Google Scholar
  37. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, 2011.
  38. J. Li, X. Li, Q. Wang et al., “ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data,” The Lancet, vol. 385, no. 9966, pp. 441–451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Matsumura, R. W. Jeremy, J. Schaper, and L. C. Becker, “Progression of myocardial necrosis during reperfusion of ischemic myocardium,” Circulation, vol. 97, no. 8, pp. 795–804, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Cao, X. Lv, Y. He, and K. Liao, “Effect of Danhong injection in hemorheology in old patients with acute coronary syndrome,” Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, vol. 18, pp. 541–542, 2010. View at Google Scholar
  41. Z.-Q. Chen, L. Hong, and H. Wang, “Effect of danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy,” Chinese Journal of Integrated Traditional and Western Medicin, vol. 29, no. 8, pp. 692–694, 2009. View at Google Scholar · View at Scopus
  42. D. Wang, G. Fan, Y. Wang et al., “Vascular reactivity screen of Chinese medicine danhong injection identifies Danshensu as a NO-independent but PGI2-mediated relaxation factor,” Journal of Cardiovascular Pharmacology, vol. 62, no. 5, pp. 457–465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. D. Trip, V. Manger Cats, F. J. L. van Capelle, and J. Vreeken, “Platelet hyperreactivity and prognosis in survivors of myocardial infarction,” The New England Journal of Medicine, vol. 322, no. 22, pp. 1549–1554, 1990. View at Publisher · View at Google Scholar · View at Scopus
  44. J. R. O'Brien, J. B. Heywood, and J. A. Heady, “The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction,” Thrombosis et Diathesis Haemorrhagica, vol. 16, no. 3, pp. 752–767, 1966. View at Google Scholar · View at Scopus
  45. M. I. Furman, M. R. Barnard, L. A. Krueger et al., “Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 38, no. 4, pp. 1002–1006, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Guan, Y. Yin, Y.-R. Zhu et al., “Dissection of mechanisms of a Chinese medicinal formula: danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 972370, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Liu, D. Zhang, J. Li et al., “Effects of Salvia miltiorrhiza and Carthamus tinctorius aqueous extracts and compatibility on rat myocardial ischemic reperfusion injury,” Zhongguo Zhongyao Zazhi, vol. 36, no. 2, pp. 189–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. X.-J. Ma, S.-J. Yin, J.-C. Jin et al., “Synergistic protection of danhong injection and ischemic postconditioning on myocardial reperfusion injury in minipigs,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 531–536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. S. Leon, “Exercise following myocardial infarction: current recommendations,” Sports Medicine, vol. 29, no. 5, pp. 301–311, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. G. T. O'Connor, J. E. Buring, S. Yusuf et al., “An overview of randomized trials of rehabilitation with exercise after myocardial infarction,” Circulation, vol. 80, no. 2, pp. 234–244, 1989. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Theroux, D. D. Waters, C. Halphen, J. C. Debaisieux, and H. F. Mizgala, “Prognostic value of exercise testing soon after myocardial infarction,” The New England Journal of Medicine, vol. 301, no. 7, pp. 341–345, 1979. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Y. Yeh, C. Wang, P. M. Wayne, and R. S. Phillips, “The effect of Tai Chi exercise on blood pressure: a systematic review,” Preventive Cardiology, vol. 11, no. 2, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. M. S. Lee, M. H. Pittler, and E. Ernst, “Tai chi for osteoarthritis: a systematic review,” Clinical Rheumatology, vol. 27, no. 2, pp. 211–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Wang, R. Bannuru, J. Ramel, B. Kupelnick, T. Scott, and C. H. Schmid, “Tai Chi on psychological well-being: systematic review and meta-analysis,” BMC Complementary and Alternative Medicine, vol. 10, article 23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. K. S. Channer, D. Barrow, R. Barrow, M. Osborne, and G. Ives, “Changes in haemodynamic parameters following Tai Chi Chuan and aerobic exercise in patients recovering from acute myocardial infarction,” Postgraduate Medical Journal, vol. 72, no. 848, pp. 349–351, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. R. M. Nery, M. Zanini, J. B. de Lima, R. P. Bühler, A. D. da Silveira, and R. Stein, “Tai Chi Chuan improves functional capacity after myocardial infarction: a randomized clinical trial,” American Heart Journal, vol. 169, no. 6, pp. 854–860, 2015. View at Publisher · View at Google Scholar